Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas

NCT02776163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Salivary Gland Tumors
Head and Neck Cancer

Interventions

DRUG: Nedaplatin
DRUG: Docetaxel
RADIATION: Intensity-modulated radiotherapy

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University